NEW YORK (GenomeWeb News) – Nanosphere today said that revenues for full-year 2013 nearly doubled year over year, matching the consensus Wall Street estimate on the top line.

The Northbrook, Ill.-based firm said that it recorded $10.0 million in revenues for the year, up from $5.1 million in 2012. All revenues were derived from product sales, while grant and contract revenues declined to none in 2013 from $44,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.